Skip to main content

Colorado’s First Licensed
Cannabis Research Facility

COMBINING CANNABIS AND SCIENCE

VISION

MedPharm is a phytopharmaceutical and intellectual property holding company that has been created to develop innovative cannabis products, using accepted pharmaceutical formulation techniques, to reliably produce identifiable and replicable dosage forms for human use.

MISSION

MedPharm will lead the industry in developing products to improve the human condition and better the lives of those who suffer from disease. It is MedPharm’s intent to position itself to have safe, reliable, proven products ready for Phase I formulations when such trials become available.

OBJECTIVE

Scale and implement a state-based production laboratory model to test, create and produce pharmaceutical-type cannabis, using intellectual property or proprietary formulations and methods for a variety of dosage forms.

OPERATION MODEL/SCIENCE METHODOLOGY

To provide cannabis pharmaceutical-type products using current Good Manufacturing Practices (cGMP) that would include pre-formulation, formulation development, small scale commercial manufacturing, analytical method development and validation, routine quality control analysis, and stability studies.
To create pharmaceutical dosage forms and produce ingredients utilizing pharmaceutical technology to be used in the delivery of cannabis extracts. The goal is to provide a reliable clinical effect through the use of well-crafted and well-researched oil analytics and dosage forms.
MedPharm is not making specific therapeutic claims. The use of the term pharmaceutical, pharmaceutical grade, pharmaceutical dosage forms, etc. are indicative of the process by which new formulation products will be created with the intent of accurately identifying the active ingredients and the amount of each in each dosage form using best practices associated with traditional pharmacy formulations. MedPharm is seeking to take existing anecdotal evidence and through its own formulation process further identify which cannabis varieties and strains are best suited to which disease states.

MedPharm’s founders include a pioneer and leader in cannabis cultivation, a leading pharmacy company, which specializes in formulation development and the world’s leading plant extraction company.

BOARD MEMBERS

TEAM

SALES TEAM

EMMELINE ATTOLINI

EMMELINE ATTOLINI

 

RORY BRENNAN

RORY BRENNAN

 

Slide
Slide
Slide
 
L.E.A.F Technology Powered By MedPharm
 

Leveraging our proprietary Lipophilic Enhanced Absorption Formulation (L.E.A.F.™) technology, MedPharm can target specific dosage categories, including oral, transdermal and the possibility sterile in the future.

OUR RESEARCH FACILITY

Our Services

Licensing of Technology, Products and Brands

Includes: grow, extraction, R&D, new formulations, or reformulating into products/brands for creams, suppositories, vaporizers, brands like: become, Batch etc.

Management and Consulting Services

Hands-on training of product creation and operational methodologies. MX, LLC leverages MedPharm Holdings for oversight, product development and employees.

Lease Fees on Property and Equipment

MX, LLC uses MedPharm facility and subleases the property with equipment MedPharm Holdings owns. This makes for a scalable business solution that can be taken to other markets.

Current Licensees

MedPharm Iowa
MedPharm MX

Consulting

Consulting Services

MedPharm has consulting services and can be reached at (720) 697-7555

Our Brands

Aliviar Alleviates
Become Lifestyle
Batch Extracts

Contact Us